S100P Expression in response to sex steroids during the implantation window in human endometrium

Reproductive Biology and Endocrinology

Wei Zhang²  Hexia Xia²  Xiaoli Sun²  Chengbin Ma¹  Dan Zhang² 

[1] Health Center for Women and Children, Chang ning district, Shanghai, China;Institute of Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

关键词: Hormonal regulation;    Endometrial receptivity;    Calcium-binding protein S100P;   

Others  :  829640
DOI  :  10.1186/1477-7827-10-106

 received in 2012-07-24, accepted in 2012-11-28,  发布年份 2012

【 摘 要 】

Background

S100P, a protein originally detected in the human placenta, has been found to play an important role in the development and invasion of tumors. Interestingly, we have recently discovered using data mining that S100P was considerably up-regulated during the window of implantation in the human endometrium, but little further information has been available.

Methods

Real-time PCR and immunofluorescence were performed to examine the expression and location of S100P in the human endometrium and endometrial cells. Estrogen and progesterone were added to the cultured cells to test the response of S100P to sex steroids.

Results

A dramatic peak, approximately a 100-fold increase in comparison with the proliferative and early- and late-secretory phases, was observed in the endometrium during the mid-secretory phase, which corresponds to the time of embryo implantation. Progesterone regulated the expression of S100P in both primary endometrial epithelial and stromal cells, but estrogen had no significant effect.

Conclusions

The results indicate that S100P participates in the periodic change of the endometrium under the regulation of progesterone, may be used as a unique biomarker of the receptive endometrium and play an important role in embryo implantation.

【 授权许可】

   
2012 Zhang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Achache H, Revel A: Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006, 12(6):731-746.
• [2]Wilcox AJ, Baird DD, Weinberg CR: Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999, 340(23):1796-1799.
• [3]Salamonsen LA, Nie G, Hannan NJ, Dimitriadis E: Society for reproductive biology Founders' lecture 2009. Preparing fertile soil: the importance of endometrial receptivity. Reprod Fertil Dev 2009, 21(7):923-934.
• [4]Zhang D, Sun C, Ma C, Dai H, Zhang W: Data mining of spatial-temporal expression of genes in the human endometrium during the window of implantation. Reprod Sci 2012, 19(10):1085-1098.
• [5]Becker T, Gerke V, Kube E, Weber K: S100P, A novel Ca(2+)-binding protein from human placenta. CDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur J Biochem 1992, 207(2):541-547.
• [6]Bulk E, Hascher A, Liersch R, Mesters RM, Diederichs S, Sargin B, Gerke V, Hotfilder M, Vormoor J, Berdel WE, Serve H, Muller-Tidow C: Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice. Cancer Res 2008, 68(6):1896-1904.
• [7]Abd El All H: Smooth muscle actin and s100p on non germinal centre diffuse large B cell lymphoma are adverse prognostic factors: pilot study. Diagn Pathol 2007, 2:9. BioMed Central Full Text
• [8]Amelung JT, Buhrens R, Beshay M, Reymond MA: Key genes in lung cancer translational research: a meta-analysis. Pathobiology 2010, 77(2):53-63.
• [9]Arumugam T, Ramachandran V, Logsdon CD: Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 2006, 98(24):1806-1818.
• [10]Arumugam T, Simeone DM, Schmidt AM, Logsdon CD: S100P Stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 2004, 279(7):5059-5065.
• [11]Arumugam T, Simeone DM, Van Golen K, Logsdon CD: S100P Promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005, 11(15):5356-5364.
• [12]Bartling B, Rehbein G, Simm A, Silber RE, Hofmann HS: Porcupine expression is associated with the expression of S100P and other cancer-related molecules in non-small cell lung carcinoma. Int J Oncol 2010, 36(4):1015-1021.
• [13]Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S: Functional evidence implicating S100P in prostate cancer progression. Int J Cancer 2008, 123(2):330-339.
• [14]Gibadulinova A, Tothova V, Pastorek J, Pastorekova S: Transcriptional regulation and functional implication of S100P in cancer. Amino Acids 2010, 41(4):885-892.
• [15]Hamada S, Satoh K, Hirota M, Kanno A, Ishida K, Umino J, Ito H, Kikuta K, Kume K, Masamune A, Katayose Y, Unno M, Shimosegawa T: Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Sci 2011, 102(1):150-156.
• [16]Shiota M, Tsunoda T, Song Y, Yokomizo A, Tada Y, Oda Y, Naito S: Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin. BJU Int 2010, 107(7):1148-1153.
• [17]Nakata K, Nagai E, Ohuchida K, Hayashi A, Miyasaka Y, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M: S100P Is a novel marker to identify intraductal papillary mucinous neoplasms. Hum Pathol 2010, 41(6):824-831.
• [18]Levy M, Lin F, Xu H, Dhall D, Spaulding BO, Wang HL: S100P, von hippel-lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol 2010, 41(9):1210-1219.
• [19]Arumugam T, Logsdon CD: S100P: a novel therapeutic target for cancer. Amino Acids 2010, 41(4):893-899.
• [20]Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, Pellicer A, Mosselman S, Simon C: Gene expression profiling of human endometrial receptivity on days LH + 2 versus LH + 7 by microarray technology. Mol Hum Reprod 2003, 9(5):253-264.
• [21]Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Alama P, Pellicer A, Simon C: A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril 2010, 95(1):50-60.
• [22]Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le Shay N, Nezhat CN, Kempson R, Lessey BA, Nayak NR, Giudice LC: Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006, 147(3):1097-1121.
• [23]Murray MJ, Lessey BA: Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin Reprod Endocrinol 1999, 17(3):275-290.
• [24]Kodaman PH, Taylor HS: Hormonal regulation of implantation. Obstet Gynecol Clin North Am 2004, 31(4):745-766, ix.
• [25]Paulson RJ: Hormonal induction of endometrial receptivity. Fertil Steril 2011, 96(3):530-535.
• [26]Noyes RW, Hertig AT, Rock J: Dating the endometrial biopsy. Am J Obstet Gynecol 1975, 122(2):262-263.
• [27]Arnold JT, Kaufman DG, Seppala M, Lessey BA: Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Hum Reprod 2001, 16(5):836-845.
• [28]Primer3. http://frodo.wi.mit.edu webcite
• [29]Egorina EM, Sovershaev MA, Osterud B: In-cell western assay: a new approach to visualize tissue factor in human monocytes. J Thromb Haemost 2006, 4(3):614-620.
• [30]Tong XM, Lin XN, Song T, Liu L, Zhang SY: Calcium-binding protein S100P is highly expressed during the implantation window in human endometrium. Fertil Steril 2010, 94(4):1510-1518.
• [31]Parkkila S, Pan PW, Ward A, Gibadulinova A, Oveckova I, Pastorekova S, Pastorek J, Martinez AR, Helin HO, Isola J: The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol 2008, 8:2. BioMed Central Full Text
• [32]Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, Bloethner S, Schlotterer A, Kumar R, Strowitzki T, von Wolff M: Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology 2006, 147(12):5662-5675.
• [33]Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T: The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of Cathepsin D. Cancer Res 2007, 67(18):8633-8642.
• [34]Koltzscher M, Neumann C, Konig S, Gerke V: Ca2 + −Dependent binding and activation of dormant ezrin by dimeric S100P. Mol Biol Cell 2003, 14(6):2372-2384.
• [35]Filipek A, Jastrzebska B, Nowotny M, Kuznicki J: CacyBP/SIP, a calcyclin and siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 2002, 277(32):28848-28852.
• [36]Chen Q, Zhang Y, Lu J, Wang Q, Wang S, Cao Y, Wang H, Duan E: Embryo-uterine cross-talk during implantation: the role of Wnt signaling. Mol Hum Reprod 2009, 15(4):215-221.
• [37]McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK: Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 2001, 86(8):3665-3674.
• [38]Nakamura H, Kimura T, Ogita K, Nakamura T, Takemura M, Shimoya K, Koyama S, Tsujie T, Koyama M, Murata Y: NF-kappaB activation at implantation window of the mouse uterus. Am J Reprod Immunol 2004, 51(1):16-21.
• [39]Heng S, Cervero A, Simon C, Stephens AN, Li Y, Zhang J, Paule S, Rainczuk A, Singh H, Quinonero A, Tapia A, Velasquez L, Salamonsen L, Rombauts LJ, Nie G: Proprotein convertase 5/6 is critical for embryo implantation in women: regulating receptivity by cleaving EBP50, modulating ezrin binding, and membrane-cytoskeletal interactions. Endocrinology 2011, 152(12):5041-5052.
• [40]Wang Q, Williamson M, Bott S, Brookman-Amissah N, Freeman A, Nariculam J, Hubank MJ, Ahmed A, Masters JR: Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene 2007, 26(45):6560-6565.
• [41]Hammacher A, Thompson EW, Williams ED: Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer. Int J Biochem Cell Biol 2005, 37(2):442-450.
• [42]Hamada S, Satoh K, Hirota M, Fujibuchi W, Kanno A, Umino J, Ito H, Satoh A, Kikuta K, Kume K, Masamune A, Shimosegawa T: Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines. Cancer Sci 2009, 100(1):103-110.
• [43]Chandramouli A, Mercado-Pimentel ME, Hutchinson A, Gibadulinova A, Olson ER, Dickinson S, Shanas R, Davenport J, Owens J, Bhattacharyya AK, Regan JW, Pastorekova S, Arumugam T, Logsdon CD, Nelson MA: The induction of S100p expression by the prostaglandin E (PGE)/EP4 receptor signaling pathway in colon cancer cells. Cancer Biol Ther 2010, 10(10):1056-1066.
• [44]Kino T, Manoli I, Kelkar S, Wang Y, Su YA, Chrousos GP: Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem Biophys Res Commun 2009, 381(4):671-675.
• [45]Namba T, Homan T, Nishimura T, Mima S, Hoshino T, Mizushima T: Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects. J Biol Chem 2009, 284(7):4158-4167.
• [46]Averboukh L, Liang P, Kantoff PW, Pardee AB: Regulation of S100P expression by androgen. Prostate 1996, 29(6):350-355.
• [47]Bray JD, Jelinsky S, Ghatge R, Bray JA, Tunkey C, Saraf K, Jacobsen BM, Richer JK, Brown EL, Winneker RC, Horwitz KB, Lyttle CR: Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. J Steroid Biochem Mol Biol 2005, 97(4):328-341.